| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |